FIELD: medicine, pharmaceutics.
SUBSTANCE: present group of inventions refers to medicine, namely to endocrinology, and concerns treating diabetes. That is ensured by administering a pharmaceutical composition containing an activated potentiated form of insulin receptor antibodies to and an activated potentiated form of endothelial NO-synthase antibodies.
EFFECT: method provides the effective treatment of diabetes ensured by a synergetic effect of the ingredients of the composition on reducing insulin resistance and hyperglycemia.
23 cl, 6 dwg, 5 ex
Authors
Dates
2014-03-20—Published
2011-07-01—Filed